Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery
S Waheed, Z Li, F Zhang, A Chiarini, U Armato… - Journal of …, 2022 - Springer
The rapid advancement of nanomedicine and nanoparticle (NP) materials presents novel
solutions potentially capable of revolutionizing health care by improving efficacy …
solutions potentially capable of revolutionizing health care by improving efficacy …
[HTML][HTML] Extracellular vesicles in nanomedicine and regenerative medicine: a review over the last decade
Small extracellular vesicles (sEVs) are known to be secreted by a vast majority of cells.
These sEVs, specifically exosomes, induce specific cell-to-cell interactions and can activate …
These sEVs, specifically exosomes, induce specific cell-to-cell interactions and can activate …
Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis
C Yan, J Chen, C Wang, M Yuan, Y Kang, Z Wu… - Drug …, 2022 - Taylor & Francis
The refractory diabetic wound has remained a worldwide challenge as one of the major
health problems. The impaired angiogenesis phase during diabetic wound healing partly …
health problems. The impaired angiogenesis phase during diabetic wound healing partly …
Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies
During the past decades, extracellular vesicles (EVs) have emerged as an attractive drug
delivery system. Here, we assess their pre-clinical applications, in the form of a systematic …
delivery system. Here, we assess their pre-clinical applications, in the form of a systematic …
Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy
Exosomes are a class of extracellular vesicles of around 100 nm in diameter that are
secreted by most cells and contain various bioactive molecules reflecting their cellular origin …
secreted by most cells and contain various bioactive molecules reflecting their cellular origin …
Integrating natural compounds and nanoparticle‐based drug delivery systems: A novel strategy for enhanced efficacy and selectivity in cancer therapy
Cancer remains a leading cause of death worldwide, necessitating the development of
innovative and more effective treatment strategies. Conventional cancer treatments often …
innovative and more effective treatment strategies. Conventional cancer treatments often …
Opportunities and challenges in enhancing the bioavailability and bioactivity of dietary flavonoids: A novel delivery system perspective
D Yuan, Y Guo, F Pu, C Yang, X **ao, H Du, J He, S Lu - Food Chemistry, 2024 - Elsevier
Flavonoids have multiple favorable bioactivities including antioxidant, anti-inflammatory, and
antitumor. Currently, flavonoid-containing dietary supplements are widely tested in clinical …
antitumor. Currently, flavonoid-containing dietary supplements are widely tested in clinical …
Advanced phytochemical-based nanocarrier systems for the treatment of breast cancer
Simple Summary Breast cancer is a concern for the healthcare system. Even with the
advancement of science and technology, the current system for therapeutics and diagnostics …
advancement of science and technology, the current system for therapeutics and diagnostics …
Exosomes as a next-generation drug delivery system: An update on drug loading approaches, characterization, and clinical application challenges
Exosomes are small nanoparticles secreted by almost all cells and have a well-known role
in intercellular communication. They are found in different body fluids and can also be …
in intercellular communication. They are found in different body fluids and can also be …
[HTML][HTML] Progress of exosomes in the diagnosis and treatment of lung cancer
The incidence and mortality of lung cancer account for first place all over the world. Lung
cancer lacks early diagnostic biomarkers; lung cancer patients are usually diagnosed in …
cancer lacks early diagnostic biomarkers; lung cancer patients are usually diagnosed in …